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ABSTRACT

Purpose: Left ventricular assist device (LVAD) therapy can be live-saving for advanced
heart failure patients. Conventional anastomosis (surgical connection) of LVAD outflow
grafts to the aorta requires aortic clamping and hand-suturing. Aortic clamping increases
the risk for neurological complications. Hand-suturing may be time-consuming and
requires significant surgical dexterity. There is currently no commercially available
device for sutureless anastomosis of large vascular grafts (diameter > 5mm). To
overcome these limitations, a prototype LVAD outflow graft anastomosis device (GrAD)
that facilitates sutureless anastomosis was developed and tested to demonstrate proof-ofconcept and feasibility for (1) secured attachment withstanding physiological pressures,
and (2) comparable attachment strength to conventionally hand-sewn sutured
anastomosis.
Methods: To demonstrate proof-of-concept, prototype GrADs were fabricated using a
nitinol wire connector attached to a 15 mm graft, felt flanged cuff, and cyanoacrylate
adhesive. To demonstrate feasibility, the GrAD was anastomosed to bovine descending
aorta and tested in a mock flow loop over a range of static (0, 50, 100, 150, 200 mmHg)
and dynamic pressures (normal, hypertension, heart failure, LVAD support) to quantify
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leakage. The maximum pull-out force for the GrAD and sutured anastomosis were also
measured after completing static and dynamic testing in the mock flow loop model.
Results: The GrAD remained securely attached during all static and dynamic pressure
test conditions as evidenced by minimal leak rates during clinically equivalent normal
(22.1 ± 9.3 ml/min), hypertension (23.1 ± 10.1 ml/min), heart failure (16.4 ± 6.4 ml/min),
and LVAD support (16.4 ± 4.3 mL/min) test conditions. Significantly larger leak rates at
normal dynamic pressure (120/80 mmHg) between the GrAD and previously reported
results for hand-sutured anastomosis were not observed. Differences in peak pull-out
force between GrAD (43.57 ± 17.31 N) and hand-sutured anastomosis (63.48 ± 8.72 N)
were statistically indiscernible (paired t-test, p < 0.5). No indications of device damage
were observed.
Conclusion: A prototype GrAD enabling a sutureless, adaptable, and angled LVAD
outflow graft anastomosis was developed with preliminary feasibility testing
demonstrating proof-of-concept. The proposed LVAD outflow GrAD may facilitate
surgical implant by eliminating the need for hand-suturing, decrease implant time, and
increase reliability and reproducibility with the potential to improve patient outcomes.
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I. BACKGROUND

A. Heart Failure
Heart failure (HF) is a progressive condition in which the heart muscle loses its
capacity to pump adequate blood volume to satisfy the body’s demand for oxygen and
nutrients, and removal of carbon dioxide and waste. It continues to be one of the largest
unsolved medical complications despite being one of the most explored medical diseases.
HF is the leading cause of death in the United States, affecting ~5.7 million people in the
US with a projected increase in prevalence of 46% from 2012 to 2030 (Mozaffarian et al.,
2015). In 2011, the direct and indirect costs of HF in the US was an estimated 34.4 billion
dollars (Heidenreich et al., 2011), and is projected to increase from 44.6 to 97 billion
from 2015 through 2030 (Roger et al., 2012). According to the National Center for
Health Statistics (NCHS) and the National Heart, Lung, and Blood Institute (NHLBI),
one in 9 deaths in the US have been attributed to HF. Although survival following HF
diagnosis has improved over time due to advances in medical treatment, the death rate
remains high with a ~50% mortality rate within 5 years of HF diagnosis (Levy et al.,
2002; V. L. Roger et al., 2004).
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Preferred treatment strategy(s) for HF is dependent on the type of HF and
severity. For example, symptoms are managed using pharmacologic therapy and changes
to lifestyle factors in early stage HF. Unfortunately, there is a large group of patients with
severe HF (advanced HF) that are unresponsive to pharmacologic therapy and changes in
lifestyle factors. The gold standard for treating these advanced HF patients is heart
transplantation, but the supply of donor hearts cannot satisfy the clinical demand. In
2013, only 51.1% of candidates listed for heart transplantation received heart transplants
(Colvin-Adams et al., 2014). The number of heart transplants has reached a plateau while
the number of advanced HF patients continues to grow (Figure 1). Subsequently, there is
a significant unmet clinical need and demand for alternative HF treatment options.

Figure 1: Number of heart transplants performed in North America, Europe and other countries as reported
by the International Society for Heart & Lung Transplantation Transplant Registry (Stehlik et al., 2010).
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B. Left Ventricular Assist Device (LVAD)
Left ventricular assist devices (LVADs) are blood pumps that assist the blood
pumping function of the heart in advanced heart failure patients (Figure 2). In 2006, the
Interagency Registry for Mechanically Assisted Circulatory Support Devices
(INTERMACS) reported 94 LVAD implants per year, which increased to 2,447 LVAD
implants per year in 2014 (Kirklin et al., 2015). LVADs were initially implanted as
bridge to transplantation (BTT) devices for patients with deteriorating HF that were at
high mortality risk while on the waiting list wait for a heart transplant. Due to early
success and technical advances in LVAD technology over the past 15 years, the use of
these devices has expanded to include long-term and myocardial recovery therapy.

Figure 2: Number of left ventricular assist device (LVAD) and total artificial heart implants from 20062014 as reported by the Interagency Registry for Mechanically Assisted Circulatory Support Devices
(Kirklin et al., 2014).

3

LVAD technology has evolved significantly from first-generation devices that
were large, pulsatile, volume displacement pumps to current third-generation devices that
are smaller size, lighter weight, valveless, and magnetically-levitated rotary pumps.
Technological innovations of LVADs included miniaturization of pumps, increased
durability due to less moving parts, introduction of continuous-flow pumps, and
magnetically levitated pump rotors. In parallel with the technological evolution of
LVADs, there has been a marked improvement in the survival rates after LVAD
implantation. The one-year and two-year actuarial survival rates of these continuous-flow
devices are 68% and 58%, respectively, compared to 55% and 24% for first generation
pulsatile-flow devices (Slaughter et al., 2009). In addition, there have been significantly
less clinically significant adverse events (e.g. device-related infection, non-device-related
infection, right heart failure, respiratory failure, renal failure, cardiac arrhythmia) in
patients with continuous-flow devices compared to pulsatile-flow devices (Slaughter et
al., 2009).
The success of LVADs as BTT devices combined with increased survival rates
and reduced adverse events has expanded their clinical role to permanent (long-term)
support devices (destination therapy). The Randomized Evaluation of Mechanical
Assistance for the Treatment of Congestive Heart (REMATCH) trial compared optimal
medical management (pharmacological therapy) vs Heartmate I Left Ventricular Assist
Device LVAD as permanent treatment among 129 advanced HF patients. The LVAD
group had a 52% one-year survival and 23% two-year survival compared to 25% oneyear survival and 8% for the optimal medical management (OMM) therapy (Rose et al.,
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2001). These results from the REMATCH trial led to Food and Drug Administration
(FDA) approval of a few CF LVADs for destination therapy (DT).
Clinical research has demonstrated improvements in cardiac function and reverse
remodeling with LVAD support offering hope for LVAD use as a potential therapy
strategy for sustained myocardial recovery (Frazier et al., 1996). Studies offer compelling
evidence that chronic volume unloading provided by LVADs is associated with
beneficial structural and molecular remodeling that may lead to functional improvement
(Birks et al., 2005; Birks et al., 2006; Cullen et al., 2006; Hall et al., 2007; Latif, Yacoub,
George, Barton, & Birks, 2007). For some patients, the reverse remodeling that occurs
may allow for removal of the LVAD due to regained cardiac function (Birks, 2010; Birks
et al., 2006; Dandel et al., 2005). Emma Birks et al. has pioneered the methodology of
combining the neurohormonal effects of HF medications and mechanical left ventricular
volume unloading with LVADs as a treatment strategy for myocardial recovery (Birks et
al., 2006; Lenneman & Birks, 2014). This treatment method has allowed about 2/3 of a
small cohort of patients receiving the treatment to regain cardiac function for device
removal (Birks, 2010; Birks et al., 2006). Expanding clinical indications for LVAD
therapy as BTT, DT, or myocardial recovery promotes a larger application and use of
LVADs for HF patients.

1. Surgical Implantation of LVADs
Although LVADs can be a life-saving therapy for advanced HF patients,
implantation of these devices requires a major surgical procedure that can take up to 4+
hours. Conventional implantation for popular LVAD systems in the US—Thoratec
5

HeartMate II, HeartWare HVAD, Jarvik-2000—require a median sternotomy (Figure 3),
cardiopulmonary bypass (CPB) and partial clamping of the aorta. Median sternotomy is
associated with risk of infection, high hospital stay costs, and severe burden for the
patient (Graf et al., 2010; Heilmann et al., 2013; Taylor, Mitchell, & Mitchell, 2012).
CPB is associated with post-operative bleeding (Ohri et al., 1991) and/or pulmonary
complications (Huffmyer & Groves, 2015), as well as potential risk of blood damage
(Mamikonian et al., 2014). Clamping of the aorta has been associated with increased risk
of neurological complications (Zamvar et al., 2002) and aortic dissections (Stanger,
Oberwalder, Dacar, Knez, & Rigler, 2002). These limitations have led investigators to
investigate the development of alternative surgical approaches and/or novel technologies
that may enable less-invasive implantation techniques to reduce time and facilitate
surgery and recovery.
Several investigators have reported less-invasive (Figure 3) and beating heart (offpump; without cardiopulmonary bypass) surgeries for LVAD implantation (Anyanwu,
Fischer, Plotkina, Pinney, & Adams, 2007; Cheung et al., 2011; Frazier, 2003; Gregoric
et al., 2008; Maltais, Davis, & Haglund, 2014; Rojas et al., 2015; Sun et al., 2008;
Wagner et al., 2015). For example, the Sutureless Beating Heart connector (APK
Advanced Medical Technologies, Atlanta, GA) allows for off-pump, beating heart
implantation of inflow cannulas of LVADs (Koenig et al., 2014). The combination of
less-invasive surgical approaches and novel technologies may enable less-invasive and
off-pump implantation of LVADs, thereby potentially reducing post-operative recovery
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times, cost of hospital stays, and the risk of further complications associated with CPB
and median sternotomy.

B

A

Figure 3: Images showing different surgical approaches for implanting left ventricular assist devices
(LVADs). A) Median sternotomy used for conventional implantation of LVADs (Zucchetta, Tarzia,
Bottio, & Gerosa, 2014), B) Less-invasive incisions used for implantations of LVADs, also showing
standard locations for inflow cannulation to the left ventricular apex and outflow graft anastomosis to the
ascending aorta (Gregoric et al., 2008).

2. Outflow Graft Anastomosis of LVAD
To complete the LVAD outflow graft anastomosis (surgical connection), a sidebiting clamp is placed on the ascending aorta to facilitate suturing and minimize blood
loss by creating an area of flow stagnation. A small incision is then made to the aorta
(aortotomy) to connect to outflow graft. An aortic punch is typically used to round out the
edges of the incision to prevent damage or tearing at the incision site. A 3-0 to 5-0
Prolene suture is used to hand-suture a gelatin-impregnated, woven polyethylene
terephthalate (PET) graft in a running suture technique (Figure 4). Upon completion of
the suturing, the side-biting clamp is removed and blood flow provided through the
outflow graft.
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Conventional LVAD outflow graft anastomosis requires aortic cross- or partialclamping, which as mentioned previously is associated with aortic complications. To
complete anastomosis of the LVAD outflow graft to the aorta requires surgical dexterity
and may be time-consuming (up to 30 minutes) to complete. As surgical implantation for
LVADs advance toward less-invasive, off-pump procedures, alternative solutions are
warranted for completing LVAD outflow graft anastomosis that would complement an
altogether less-invasive procedure.

Figure 4: Diagram of an end-to-side anastomosis performed using a
running suture technique (Baker, 2015).
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C. Sutureless Anastomosis

Figure 5: Timeline showing the chronological development of historical
sutureless anastomosis devices (P. Tozzi, 2007).

Historically, anastomosis has been completed using hand-suture methods based
on the principles established by Alexis Carrel in 1902 (Carrel, 1902). The reliability and
long-term patency results of this method has rooted it as the gold standard for vascular
anastomosis. Earliest scientific reports for completing sutureless anastomosis used crude
materials (e.g. quill-pens, glass, ivory cuffs, ox shin bones) as vascular prostheses (Abbe,
1894; Callow, 1982; Muir, 1914; Nitze, 1897; Tuffier, 1915). More promising
technologies were introduced in the 1900s that employed interlocking rings (Berggren,
Ostrup, & Lidman, 1987; Nakayama, Tamiya, Yamamoto, & Akimoto, 1962; Payr,
1904), symmetrical anvils (Daniel & Olding, 1984), staples (Androsov, 1956), heatshrink tubing (Mattox & Wozniak, 1991), and clips (Kirsch, 1998). Less mechanical
approaches for sutureless anastomosis included the combination of lasers with stay
stitches (Grubbs et al., 1988; Jain & Gorisch, 1979; Phillips et al., 1999). None of these
9

devices were widely accepted due to limitations that included complex and cumbersome
instrumentation, rigid foreign bodies, and poor clinical results (P. Tozzi, 2007).

D. Devices for Sutureless Anastomosis
Currently there are no commercially available devices for sutureless anastomosis
of large-diameter synthetic grafts (>5 mm), similar to those used for LVAD outflow
grafts. The majority of devices enabling sutureless anastomosis were developed for
facilitating coronary artery bypass graft (CABG) procedures, which require end-to-side
anastomosis of small-diameter arteries/veins (<5 mm). These devices may be categorized
as proximal (anastomosed to the ascending aorta) or distal (anastomosed to the
descending aorta) anastomotic devices.

Figure 6: Photograph of the first generation St. Jude Medical Symmetry Aortic
Connector. Aortic wall is compressed between internal and external struts. Connection
with the vessel is achieved with vein hooks (P. Tozzi, 2007).

The St. Jude Medical Symmetry Aortic Connector was the first nitinol connector
to gain clinical approval (P. Tozzi, 2007). Nitinol is a Nickel and Titanium alloy that
exhibits superelastic and shape-memory properties enabling it to return to an original
shape after large deformations. This star-shaped connector attaches vein grafts at a 90°
10

angle to the proximal aorta by compressing the aortic wall between internal and external
struts (Figure 6). Once a graft vein is excised, it is loaded onto the delivery system.
Hooks arranged around the inner ring of the connector fasten to the vein. A limitation of
this device is that only a single end of the vessel can be anastomosed since a free-end is
required for loading onto the deployment tool. Furthermore, the 90° take-off angle
requires precise placement of the graft vessel to avoid graft kinking. Of the 44
anastomoses constructed by the Symmetry Aortic Connector 55% were occluded (Figure
7) at a mean follow-up period of 41 months (P. Bergmann et al., 2007). In another study,
74 patients underwent elective CABG in which 131 anastomoses were constructed using
the Symmetry Aortic connector, in which 20 bypass grafts (2 hand suture, 18 Symmetry)
showed severe stenosis or occlusion (Traverse et al., 2003). Although the Symmetry
device reliably allows blood flow acutely through an anastomosis (Dewey et al., 2004;
Eckstein et al., 2002), long-term clinical results discouraged the continued usage of the
device.

Figure 7: Photograph showing occlusion of St. Jude Medical
Symmetry Aortic Connector one-month after implantation due
to intima hyperplasia onto the struts (P. Tozzi, 2007).
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Figure 8: Drawings showing the Cardiovations CorLink device. A) CorLink device being loaded with a
graft vessel inserted through the side of the insertion tool, vessel-end everted, and pins penetrating through
the everted vessel (Bar-El, Tio, & Shofti, 2003), B) CorLink device deployed into the side of a vessel
showing pins penetrating intima and struts compressing the exterior surface of the vessel (Riess et al., 2002)

Other devices that allow anastomosis between the ascending aorta and a graft
vessel include the CorLink (Cardiovations, Somerville, NJ) and Spyder (Coalescent
Surgical, Sunnyvale, CA). The CorLink is a nitinol connector that requires a graft vessel
to be everted over the end of the connector, which may be cumbersome and/or damage
the vessel intima (innermost cellular layer in contact with blood flow), as shown in
Figure 8. The graft vessel is pulled through an insertion tool for deployment (Figure 8).
The mechanism of loading the vessel through the side of the integrated deployment tool
offers the advantage of not requiring the graft to have a free-end. For this device to
successfully attach to a target vessel, two sets of five pins must fully-penetrate through
the vessel. The Spyder uses a novel approach of depositing 6 nitinol sutures (U-clips)
between a pre-mounted vein graft and the aorta, resulting in a connection similar to an
interrupted suture technique without the requirement of tying nots. Both the Corlink and
Spyder devices demonstrated higher incidence of occlusion versus standard suture
anastomosis, as well as failed to create hemostasis upon deployment (Biancari et al.,
2007; Gummert et al., 2007). These devices had limited foreign body exposure, but the
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increased vascular injury from penetration of pins/clips may have alternatively triggered
intimal hyperplasia (proliferation of intimal cells decreasing vessel lumen space) and
gradual occlusion of the graft. These pre-clinical and clinical results failed to gain the
enthusiasm for adoption of these devices, therefore these devices are no longer used
clinically.

Figure 9: Images of the PAS-Port proximal aortic connector. A) Integrated deployment and aortotomy
tool, B) Loaded vessel being deployed onto the proximal aorta, C) PAS-Port connector after deployment
onto the aortic wall showing compression of the vessel wall without penetration (Dohmen et al., 2011).

The PAS-Port (Cardica Inc, Redwood City, CA) is the only commercially
available proximal anastomosis system that is currently distributed in both Europe and
the US (Figure 9). Unlike aforementioned devices, this novel device integrates the action
of the aortotomy and deployment of the connector into a single tool. After loading the
graft vessel onto the deployment tool, the tool is placed onto the target location and the
surgeon rotates a knob on the tail-end of the tool to complete the anastomosis. In the
pivotal EPIC trial, 220-patients requiring CABG with at least 2 vein grafts randomly
received one graft with the PAS-Port device, and the other with a hand-sewn suture
method. Results showed an 80.3% 9-month graft patency (state of being unblocked)
versus 82.0% for hand-sewn. Similar freedom from major adverse cardiac events at 9-
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months was demonstrated between the two methods. However, the PAS-Port system was
associated with a statistically significant, 4.6 ± 3.9 minute reduction in anastomotic time
from the overall 7.7 ± 2.9 minutes required to complete conventional hand-sewn
anastomosis(Puskas et al., 2009). Promising mid- to long-term results were also
demonstrated in Japan (Kai et al., 2009) and Europe (Gummert et al., 2006).
Technological innovations of the PAS-Port system include: 1) Integrated aortotomy and
deployment tool, 2) Reduced non-biologic material exposure inside the vessel lumen, 3)
Utilization of 316L stainless-steel material in replacement of nitinol. These
characteristics may have contributed to the greater clinical results of PAS-Port system
compared to preceding devices.

Figure 10: Images of the Converge Coronary Anastomosis Coupler and the Cardica C-port anastomosis
devices. A) Converge Coronary Anastomosis Coupler attached to an artery showing angled anastomosis
through attachment of two coupled connectors (Boening et al., 2005), B) Cardica C-port anastomosis
device showing angled anastomosis through stapling in a interrupted suture manner (P. Tozzi, 2007).

The second category of sutureless anastomotic devices are intended for distal
anastomosis. Some of the more promising distal anastomotic devices are the Converge
Coronary Anastomosis Coupler (Converge Medical Inc., Sunnyvale, CA) and the Cardica
C-Port (Cardica Inc., Redwood City, CA). The Converge device is a two-piece coupler
made of nitinol that clamps the vessels being anastomosed together (Figure 10). The graft
vessel is placed between the two frames, which is loaded into a dedicated deployment
14

tool for insertion into the target artery at a 30° take-off angle. Loading of the coupler has
been reported to be cumbersome and anastomosis leak has been common (Boening et al.,
2005). The C-port is an anastomosis device that deposits stainless steel staples to form an
end-to-side anastomosis similar to an interrupted suture technique (Figure 10). In a
single-center study, the anastomotic patency of the Cardica C-Port was compared to the
hand-sew anastomosis. One-year patency rates between the two techniques showed no
statistically discernible differences, and the incidence of complications was comparable
to the hand-sewn anastomosis (Verberkmoes et al., 2013). The C-port is particularly
promising because it creates an angled anastomosis, has similar non-intimal surface as a
sutured anastomosis thereby requiring no anticoagulation therapy, and is capable of
creating a side-to-end anastomosis in very small (1mm) diameter vessels (P. Tozzi,
2007).

Figure 11: Photograph showing the end-to-side version of the Vascular Join anastomosis
device. End of a synthetic graft is fastened to the prosthesis and a saddle element is fastened on
to the side of the target vessel through connection of hooks into the wall of the vessel (P. Tozzi,
2007).

One of the most promising sutureless devices that addresses the limitations of
vascular injury and foreign-body blood exposure is the Vascular Join (Idee & Sviluppo
LLC, Bologna, Italy). The Vascular Join consists of two metallic rings that are fixed to
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the exterior of either a biologic or synthetic graft (Figure 11). There are various sized
elements accommodating 3 to 12 mm diameter grafts, but there are no restrictions in
respect to vessel size. For end-to-side anastomosis, a saddle element is attached to the
exterior of the desired side vessel by hooks that only penetrate the vessel wall without
full-thickness penetration. After creation of an elliptical hole with a dedicated rotary
blade, the graft with a pre-mounted ring is inserted to create the anastomosis. The device
provides reproducible anastomosis with biologic and synthetic grafts with the advantages
of zero foreign-body exposure to blood, angled geometry, and may be adapted to any size
graft regardless of graft diameter and thickness. Clinical results for the end-to-end
version of the Vascular Join showed 100% patency, immediate hemostasis, adequate
blood flow and no instances of technical failure (Ferrari, Tozzi, & von Segesser, 2007).
Long-term and end-to-side clinical studies are needed in order for this device to gain
wide clinical acceptance.
All of the aforementioned devices, except the Vascular Join, are limited to
applications of attaching small biologic vessels to either the ascending or descending
aorta. None of these devices were designed for LVAD outflow grafts anastomosis, hence
have not been tested in relevant models consisting of end-to-side anastomosis to a large
aortotomy (>5 mm diameter) under turbulent and high pressures common to the
ascending aorta. There are currently no commercially-available devices or scientific
reports of sutureless anastomotic devices for LVAD outflow grafts, providing an
opportunity for the development of innovative technologies to facilitate anastomosis of
LVAD outflow grafts.
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E. Surgical Adhesives
Surgical adhesives are a promising and growing area for development due to
many potential clinical applications. Currently, octyl cyanoacrylate (Dermabond) is in
use clinically to replace sutures for incisional or laceration closure (Bruns &
Worthington, 2000). Other adhesives, such as fibrin sealants (e.g. EVICEL, TISSEAL),
are clinically approved as an adjunct to standard sutures for hemostasis. Fibrin adhesives
have shown to be highly effective in preventing leaks in conjunction with sutures for
vessel-to-vessel anastomosis, as well as synthetic graft-to-vessel anastomosis (Saha et al.,
2012). In the application of wound closure, adhesives over the advantage of fast
application, less traumatic closure, and the ability for application within difficult working
environments.
Many hemostatic adhesives have been developed based on fibrin, collagen,
cyanoacrylate (Hee Park et al., 2003; Szanka, Szanka, Şen, Nugay, & Kennedy, 2015),
polyethylene glycol (Marc et al., 2000), albumin-glutaraldehyde (Küçükaksu, Akgül,
Çağli, & Taşdemir, 2000; Mitrev, Belostotskii, & Hristov, 2007), or gelatin-resorcinalformaldehyde (Perrin et al., 2009). Other adhesives have drawn inspiration from nature,
such as citrate-based mussel-inspired adhesive (Mitrev et al., 2007), and poly(glycerol
sebacate acrylate)-based gecko-inspired adhesive (Mahdavi et al., 2008). Requirements of
an ideal hemostatic surgical adhesive is that it must be easy to use, safe, polymerize in a
wet environment, and have strong adhesion properties. Development of a strong
hemostatic adhesive with these properties has the potential of replacing sutures.
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Several studies have attempted replacement of sutures with available hemostatic
adhesives. Fibrin- and cyanoacrylate-based adhesives has been used to complete
microvascular anastomosis (Carton, Heifetz, & Kessler, 1962; Carton, Kessler,
Seidenberg, & Hurwitt, 1960; Carton, Kessler, Seidenberg, & Hurwitt, 1961; Ikossi‐
O'Connor, Ambrus, & Rao, 1983; Kim et al., 2004). However, fibrin adhesives are
inherently weak adhesives and has not been reported to be used alone in high pressure
arterial applications. Inadvertent entrance of both fibrin and cyanoacrylate may risk
thrombus (blood clot) formation (Ang, Tan, Tan, Ng, & Song, 2001; LeMaire et al.,
2005; Middleton, Matthews, & Chiasson, 1991). Although cyanoacrylate-based adhesives
have strong adhesive properties, they have been associated with anyeursmal dilatation
(Carton et al., 1961) and tissue necrosis (Takenaka, Esato, Ohara, & Zempo, 1992).
Recently developed adhesives have had promising results in repairing of high-pressure
cardiovascular defects. One of the most promising adhesives is a hydrophobic light
activated adhesive that demonstrated capability of closing 3 to 4 mm carotid artery
defects and 2 mm full-thickness defects of the left ventricle in combination with a patch
(Lang et al., 2014). Although this adhesive has shown comparable adhesive strength with
cyanoacrylate adhesives, without the toxic effects, long-term studies are required for
clinical approval.
A separate strategy that has been employed for replacing sutured anastomoses is a
hybrid approach combining surgical adhesives with a mechanical coupling. Buijsrogge et
al. reported a technique for end-to-side anastomosis using a extraluminal stainless steel
frame with 4 downward facing hooks (Figure 12) (Buijsrogge et al., 2002). The device is
inserted into the target vessel by inserting each hook element, then octyl-cyanoacrylate
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adhesive is applied to consolidate the connection. Limitations of the device include a
critical incision length, high external ring frame that can lead to kinking, and the adhesive
used is only approved for external use (P. Tozzi, 2007). Other hybrid approaches have
combined cuff systems with an adhesive, but all reports were limited to small vessels or
low-pressure venous applications (Galvao, Bacchella, & Machado, 2007; Sacak, Tosun,
Egemen, Sakiz, & Ugurlu, 2015).

Figure 12: Drawing showing a hybrid mechanical and adhesive anastomosis device. Stainless steel ring
has 4 hooks extended axially with thickening at the end that are elastic and can be bent for insertion.
Vessel connection is consolidated by cyanoacrylate adhesive (P. Tozzi, 2007).
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F. Device Design for LVAD Outflow Graft Anastomosis Device (GrAD)
The standard running suture technique is the preferred method for LVAD outflow
graft anastomosis. However, this technique may be time-consuming, difficult to perform
in constrained surgical spaces, and requires clamping of the aorta. Further, the
progression of LVAD implantation surgery toward less-invasive and off-pump
procedures increases the technical difficulty of completing standard hand-sewn LVAD
outflow graft anastomosis due to uncompensated aortic flow dynamics and smaller
surgical spaces. These limitations of the standard sutured anastomosis motivates the
development of a novel method for sutureless LVAD outflow graft anastomosis.

1. Design Requirements for a LVAD Outflow GrAD
Table 1: Physiologic and mechanical design requirements for an LVAD outflow graft anastomosis device
(GrAD).

Physiologic Design Requirements
Minimal foreign-body non-intimal surface area
Minimal tissue trauma
Minimal alteration of native tissue compliance
Smooth profiles complementing intimal wall
Angled conformation
Clampless

Mechanical Design Requirements
Adaptable to range of graft diameters
Adaptable to range of wall thicknesses
Attachable/detachable
Easily deformable and elastic
Easily deployable in small spaces
Recovery mode for device failure
Economical

The general design criteria for an LVAD outflow graft anastomosis device
(GrAD) are listed in Table 1. Any foreign material in the blood stream will likely trigger
an inflammatory response (Anderson, Rodriguez, & Chang, 2008) and increase vessel
wall stress (Scheltes, Heikens, Pistecky, van Andel, & Borst, 2000). Additionally, foreign
materials elicit intimal hyperplasia leading to gradual decrease of effective luminal area
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for blood to flow. Tissue trauma, which may be caused by suture or pin vessel wall
penetration, is another source contributing to triggering an inflammatory response and
intimal hyperplasia (Kornowski et al., 1998). In principle, a device with zero foreignbody non-intimal surface exposure and tissue trauma is desirable to minimize
inflammatory response, increase in wall stress, and intimal hyperplasia.
Minimal alteration of the native compliance at the anastomosis, smooth profiles of
the device to the intimal wall, and angled conformation minimize the negative effects of
the device on vessel wall and blood flow properties. Sutured anastomoses are often
associated with changes in vessel compliance observed through increased wall rigidity
and alteration of elastic modulus at the anastomotic site (N. Baumgartner, Dobrin,
Morasch, Dong, & Mrkvicka, 1996). There may also be a reduction in luminal area
observed at the sutured anastomoses, which has been shown to reduce further during
systole (Figure 13) or as blood pressure increases (Tozzi et al., 2000a, 2000b). Abrupt
profiles of devices to the intimal wall may disrupt the natural wall shear stress patterns,
which is associated with thrombus formation and intimal hyperplasia (Fillinger et al.,
1990; Ojha, 1994). Studies have demonstrated that anastomosis angle affects blood flow.
The ideal anastomosis angle should be 30° to 45° (P. Tozzi, 2007). Anastomosis angles >
60° demonstrate reductions in expected flow and creation of blood stagnancy areas (Leva
& Engström, 2003; Zhang, Moskovitz, Piscatelli, Longaker, & Siebert, 1995). Therefore,
highly compliant, smooth profiled, and angled anastomosis may reduce the disposition
for the development of myiointimal hyperplasia and thrombus formation, as well as
minimize the alteration of native vessel and blood flow properties at the anastomosis.
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Figure 13: Diagram showing systolic movement of vessel edges at the anastomosis due to
sutured anastomosis. Schematic shows the reduction in cross-section lumen at systole or higher
pressure (P. Tozzi, 2007).

Clamping of the aorta creates an area of blood stagnancy such that an aortotomy
can be created without the risk of hemorrhage (major loss of blood). Aortic clamping
increases the risk of neurological complications (Zamvar et al., 2002) and aortic
dissections (Stanger et al., 2002). For CABG procedures, clampless and off-pump
procedures demonstrated lower mortality and stroke rates (Borgermann et al., 2012). A
device allowing clampless anastomosis could similarly reduce the risk for any neurologic
or aortic complications due to LVAD outflow graft anastomosis.
An LVAD outflow GrAD should be adaptable to a wide range of graft diameters
and aortic wall thicknesses. LVAD outflow graft diameter range from 10 mm to 20 mm,
varying between LVAD types. Aortic wall thicknesses may range from 2 mm to 4 mm
based on sex, race, and age shown in Table 2. Wall thickness variability arises with
elderly HF patients with calcified aortas that is shown to be associated with aortic wall
thicknesses > 4 mm (Jang et al., 2012). To allow anastomosis of all LVAD outflow grafts
to any patient, the GrAD should accommodate all graft diameters and adapt to any aortic
wall thicknesses. LVAD outflow graft lengths are tapered to each patient by positioning
the graft in its desired location and cutting off any unnecessary length in order to reduce
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the risk for graft kinking due to superfluous graft length in the constrained thoracic
cavity. Some LVAD systems require the inflow end of the graft to be secured prior to
completion of the outflow anastomosis, limiting the surgeon to a single free-end of graft.
An attachable anastomosis system would allow surgeons to appropriately size grafts to
patients then attach the anastomosis system to the free-end. An easily deformable and
elastic device are important characteristics for development of an efficient deployment
mechanism for the device, allowing it to remain undamaged when collapsed into a
deployment catheter or sheath. An easy deployment mechanism is especially critical in
less-invasive procedures where surgical windows are confined. A method for safe
recovery of the anastomosis in the case of device failure is also of critical importance
since failure of an anastomosis may lead to catastrophic hemorrhage and potential death.

Table 2: Average and maximum wall thicknesses of ascending aorta. Large variability in wall
thicknesses is shown based on sex, race, and age (Li et al., 2004).
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2. Design Considerations for LVAD Outflow GrAD
There are three main design considerations for the development of a LVAD
outflow GrAD:
1) Graft-to-vessel connection
2) Materials
3) Anastomosis biomechanical properties

3. Graft-to-Vessel Connection
There are four main mechanisms for connecting a sutureless device with either a
graft or vessel: Pins, wall eversion, wall compression, and adhesion. Pins penetrate
through the wall from either the inner lumen to the outside or from the opposite direction.
If the pins push from the inside to the outside it allows the device to push outward
radially reducing the risk of hemorrhage and generation of a dissection. If pins push from
the outside to the inside the opposite occurs and there is an increased risk for hemorrhage
and generation of dissection.
Wall eversion is restricted to the tubular member with a free-end and typically
employs an anvil to achieve eversion. This technique has larger implications for vesselto-vessel anastomosis, because it permits intima-to-intima contact. However, the main
limitation of wall eversion is potential damage to the tissue itself as it is being everted,
which is not a factor since the tubular member with a free-end being anastomosed would
be a synthetic graft.
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Wall compression is the most non-traumatic for the vessel wall if the two surfaces
creating the compression are designed to allow for nutrient perfusion to the vessel wall
itself. The advantage of this approach is it can easily be attached and detached. The
limitation of this connection type is that it provides limited strength that can be
catastrophic if it were to disconnect. Design limitations of previous devices relying on
wall compression for connection include the amount of foreign material exposed inside of
the vessel lumen. Coronary stents have demonstrated that large amounts of foreign
material inside of vessel lumens results in intimal hyperplasia and re-stenosis (Lal et al.,
2003). Another design limitation of previous wall compression devices is the strict design
constraints for wall-thickness due to a single-body component participating in the
compression.
Adhesive connection for anastomotic applications has been discussed earlier.
Adhesives offer the advantage of minimal foreign-body exposure to the inner lumen. The
main limitation of current hemostatic adhesives is that they have inadequate adhesive
strength to connect tubular members alone or have toxic and/or thrombogenic properties
in vascular applications.

4. Materials
Critical to any material implanted in the human body is that the material can
interface with tissues without causing unacceptable harm to the body. Second, the
material must have necessary material properties to accomplish and sustain their function
for its intended implantation duration. For LVAD outflow graft anastomosis, materials
must be capable of sustaining attachment to the continuously moving aorta for up to 8
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years--the longest duration a LVAD has been implanted. Further, materials may contact
blood flow exposing them to turbulent pressure and flow. Therefore, a LVAD outflow
GrAD must ensure attachment in a dynamic environment to enable LVAD flow to the
aorta, while having minimal impact on the major role of the aorta to dampen pulse
pressures and provide blood to the body.
Materials that have been used for cardiovascular applications include shapememory alloys and polymer textiles. Nitinol is one of the most commonly used metals for
fabrication of sutureless anastomosis devices in the form of connectors, anvils, and selfclosing sutures. Alternative metals that are also commonly used are stainless steel and
cobalt-chromium alloy. These metals allow for fabrication of devices that can be
collapsed into deployment tools for introduction through limited surgical spaces and
deployment into their desired location. With limited blood exposure area, these baremetals have served well as anastomosis connectors. Intimal hyperplasia is the main cause
of long-term failure associated with metallic devices as tissue proliferation leads to
narrowing and obstruction. Trauma to the nearby tissue from metallic devices leading to
intimal hyperplasia is due to physical irritation rather than chemically induced from
corrosion of the metal (Williams, 2008), suggesting that these metals have adequate
corrosion resistance. When using shape-memory alloys, designs should minimize the
surface area of the material exposed to blood and potential for vessel trauma (e.g. vessel
penetration, friction rubbing) to reduce the extent of intimal hyperplasia.
Expanded polytetrafluoroethylene (ePTFE) and polyethylene terephthalate (PET,
Dacron) compose the majority of polymers used for fabrication of vascular grafts and
sewing rings. These polymers react similarly within the human body (Mueller &
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Dasbach, 1994). Upon implantation, thrombus is formed within the pores and cellular
infiltration occurs. Then cellular proliferation via fibroblasts provides tissue in-growth
with connective tissue. For inner lumen surfaces of vascular grafts, intimal hyperplasia
leads to deposition of cell layers lining the inner surface of the graft. Synthetic grafts are
recognized to function reasonably in large diameter and high flow applications, where
narrowing due to intimal hyperplasia has a smaller impact on overall flow and rarely
leads to obstruction. The few reported cases of LVAD outflow graft obstruction were due
to factors extrinsic to the graft (Bergmann, Kottenberg-Assenmacher, & Peters, 2007;
Frogel, Vodur, & Horak, 2008; Kaplon et al., 2001; Weitzel, Puskas, Cleveland, Levi, &
Seres, 2009). There are reports of synthetic graft degradation after 15 years of implant
(Shiiya, Kunihara, Matsuzaki, & Sugiki, 2006; Van Damme, Deprez, Creemers, & Limet,
2005), however, the duration for graft degradation far exceeds that of current LVAD
implantation durations. Therefore, ePTFE and PET should be acceptable graft materials
for fabrication of a GrAD.

5. Biomechanical Properties
The natural biologic properties of vessels are altered by anastomosis, such as
vessel compliance. Generally, more compliant anastomosis devices impart less influence
on the natural elastic properties of the vessel which may reduce changes in wall stress
and risk for intimal hyperplasia. It can be speculated that sutureless anastomosis devices
fabricated from shape-memory alloys and elastic polymers will be more compliant that
running suture anastomosis since these materials are more elastic than polypropylene
suture. Alterations in blood flow is another concern as anastomosis angle and material
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profiles in the blood stream may affect the flow patterns and wall shear stress at the
anastomosis. Therefore, a highly compliant and 30° to 45° angle anastomosis, and
smooth profiles of foreign bodies conforming to the luminal vessel wall may reduce
potential risk of complications inherent to alterations of biomechanical properties of the
native aorta. Patched or cuffed anastomoses have demonstrated better patency (Brumby,
Petrucco, Walsh, & Bond, 1992) and lower peak wall shear stress (Harris, 1999; Walsh,
Kavanagh, O'brien, Grace, & McGloughlin, 2003). Subsequently, a sutureless LVAD
outflow GrAD should promote the native biomechanical properties of the blood vessels
and natural blood flow.
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II. METHODS

A. Study Design

The objective of this study was to develop a LVAD outflow GrAD to facilitate
anastomosis to the ascending aorta. To demonstrate proof-of-concept, the following aims
were proposed:
1) Complete fabrication of a device enabling sutureless anastomosis of LVAD
outflow graft to the ascending aorta
2) Complete feasibility testing of candidate prototype GrAD to demonstrate
secure connection under static and dynamic pressures
3) Complete feasibility testing of candidate prototype GrAD to demonstrate
comparable attachment strength as standard sutured anastomosis technique

Figure 14: Diagram showing experimental design consisting of static and dynamic pressure, and pullout tests.
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To successfully complete the proposed aims, three studies were completed: 1) static

pressure testing (n=3), 2) dynamic mock loop pressure testing (n=3), and 3) paired pullout force testing to compare GrAD to sutured anastomosis (n=3) (Figure 14).

A

B

C

D

Figure 15: Photographs of various views of the prototype LVAD outflow graft anastomosis device
(GrAD) consisting of a nitinol connector fastened to a 15 mm vascular graft and felt flanged cuff:
A) Side-view, B) Top-view, C) Bottom-view, D) Top-view inside lumen of graft

The prototype GrAD comprised of an attachable nitinol connector, polymer felt
flanged cuff, and adhesive (Figure 15). Prototypes of the components were fabricated and
tested experimentally to investigate smooth conformation in plastic models and bovine
aorta specimens. Preliminary testing of several adhesives was completed to assess
capability of adhering the device to aortic tissue while maintaining connection without
significant fluid leakage. The anastomosis device was tested in static pressure and
dynamic mock loop pressure models using harvested bovine descending aorta and deionized (DI) water. Paired mechanical pull-out experiments for device completed
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anastomosis and hand-sewn suture anastomosis attached to bovine descending aorta were
performed to quantify peak tensile force measured in Newtons (N) before failure.

B. Prototype Design Development
Literature, patent application, and patent reviews were conducted to evaluate intellectual
property of other potential competing devices developed for sutureless and end-to-side
anastomosis. Based on the literature and patent review, and design considerations for a
sutureless LVAD outflow GrAD, design specifications were established, as shown in
Table 1. The design of combining a nitinol connector, polymer felt flanged cuff, and
adhesive was selected for further development. Curvature of the CADs were dimensioned
based on human adult ascending aorta dimensions (Rylski, Desjardins, Moser, Bavaria, &
Milewski, 2014).

C. Nitinol Connector Fabrication
In order to fabricate each nitinol connector, metal frames were used to mount the
wire into its desired shape, annealed in a high-temperature oven, and quenched in a coldwater bath. Flat and curved nitinol connectors were fabricated using several different
gauges of nitinol wire. The various nitinol connector types were assessed for strength and
fit using plastic model of an aorta (section of Zygon tubing) and bovine descending aorta
(Figure 16).
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Figure 16: Photographs of preliminary fit studies of the nitinol connector within silicone tubing and
bovine descending aorta specimens. A) Curved nitinol connector within silicone tubing showing curvature
due to forces exerted by the tubing, B) Struts of a flat nitinol connector protruding out of the aorta due to
rigidity of thick wire gages, C) Poor conformation of a flat nitinol connector to the inner lumen aortic wall
that have the potential for causing complications
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1. Frame Construction

A

B

C

Figure 17: Photographs of the nitinol connector frame fabrication. A) Mill used for boring holes
according to template mounted onto copper slip coupling, B) Copper slip coupling used to create curved
nitinol connectors, C) Steel plate used to create flat nitinol connectors.

For flat nitinol connector frames, 3.175 mm thick flat stainless steel plates were
cut into 31.175 mm x 31.175 mm squares. For curved nitinol connector frames, 31.75
mm outer diameter copper slip couplings were used. Template drawings directing
placement of screws for molding the nitinol shape were created using SOLIDWORKS
2015 and attached to the frames. With a mill, 2.0 mm titanium drill bit was used to bore
holes for setting main shape of the connector and a 2.4 mm titanium drill bit was used for
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anchoring the nitinol wire. Each hole was threaded using a 2-56 and 4-40 tap and die set
for the 2.0 and 2.4 mm bored holes, respectively. Stainless steel screws corresponding to
the threaded hole size were inserted into the frames. Photos of the completed frames are
shown in Figure 17.

2. Shape Setting Nitinol
Super elastic temper, light oxide nitinol round wire (0.76, 0.50, 0.40, 0.36, 0.23,
and 0.18 mm gauge) was used to create the nitinol connectors. The end of the nitinol wire
was secured to the frames using binder clips and reinforced by wrapping the wire several
times around the 4-40 anchoring screws. Then the wire was wrapped tightly around each
of the 2-56 screws to form the desired shape and each screw was tightened to ensure that
the wire was held securely in tension. The free-end of the wire was anchored by wrapping
the wire around the anchoring screw. Excess wire was removed and the remaining end
was secured to the frame with a second binder clip.

Figure 18: Photograph of candidate prototype nitinol connectors of various wire gauges, curved/flat
members, and with/without loops.

Nitinol frames were placed in a Thermolyne Benchtop Muffle Furnace
(ThermoScientific, Waltham, MA) pre-heated to 530°C for 9 minutes. Frames were
removed from the furnace and quenched immediately in a room temperature bath of DI
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water. After cooling, the frames were air-dried. Each screw was loosened and the wire
was carefully removed from the frames. Excess wire was removed and the loose ends
were fastened together using 2-0 Black Braided silk suture (Ethicon, Somerville, NJ).
Figure 18 shows various candidate nitinol connectors that were assessed for fitting.
A single end of a 15 mm Gelweave Gelatin Impregnated Woven Vascular
Prosthesis vascular graft (Vascutek Ltd, Glasgow, UK) was cut at a 45° angle. Each
nitinol connector was fastened to the graft with 7 radially tied 2-0 Ethibond Excel
polyester suture (Ethicon, Somerville, NJ). Combined graft and nitinol connector were
inserted into 19.05 mm inner diameter Zygon silicone tube (Saint-Gobain North America,
Malvern, PA) through a 15.0 x 21.2 mm axes elliptical hole. Combined graft and
connector were assessed for ease of insertion and smooth conformation to the inner
lumen. Select nitinol connector designs were further assessed using bovine descending
aorta specimens for identical assessment parameters. Based on these preliminary
assessments, additional 0.36 mm gauge curved nitinol connectors were fabricated for
further experimentation (Figure 19).

Figure 19: Photographs of 0.36 mm gauge nitinol connector providing smooth conformation to the luminal
wall of a bovine descending aorta specimen.
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D. Felt Flanged Cuff Fabrication
Medical-grade polymer felt was cut and hand-sewn using 2-0 Ethibond Excel
polyester suture (Ethicon, Somerville, NJ) to construct the flanged cuff structure as
shown in Figure 20. Three coats of GE Silicone II (General Electric, Fairfield, CT) were
applied to the exterior of each cuff, allowing each coat to cure for at least 30 minutes
before re-application. After application of the final coat, they were allowed to dry for 24
hours before initiating static and dynamic pressure testing.

B

A

Figure 20: Photographs of prototype felt flanged cuff. A) Sewn flanged cuff without silicone coating,
B) Flanged cuff with 3 coats of silicone.

E. Bovine Aorta Specimens
Descending aorta specimens were excised from adult male jersey calves within 6
hours of euthanasia. Specimens were removed carefully to maintain as much length of
any branching arteries. Each vessel was immediately submerged in 3°C Belzer UW Cold
Storage Solution (Bridge to Life Ltd., Columbia, SC) and cryopreserved at -80°C.
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F. Static and Dynamic Pressure Testing
Cyanoacrylate, octylacrylate, and fibrin/thrombin adhesives were tested for
adequate attachment strength of the GrAD to the bovine descending aorta specimens. The
selected adhesive for attachment was cyanoacrylate. After thawing bovine descending
aorta specimens, any branching arteries were tied off using 3-0 silk ties. If there was
inadequate length to tie off branching arteries, 5-0 Prolene suture was used to cinch the
hole shut and a drop of cyanoacrylate adhesive was applied for sealing. Tubing
connectors were inserted into each end of the aorta specimen and secured using a
combination of 2-0 silk ties and zip ties. Elliptical aortotomies were created in bovine
descending aorta specimens (n=3) with major and minor mean axis ± standard deviation
lengths of 10.5 ± 0.4 mm and 15.7 ± 0.9 mm, respectively. Combined graft and nitinol
connectors were inserted through the aortotomy. Using opposition by pulling the free-end
of the graft, the flanged cuff was slid down the exterior of the graft to interface snug with
the exterior of the aorta. .07 mL of cyanoacrylate adhesive was applied between the
flanged cuff and vessel, and between the graft and flanged cuff. Each anastomosis was
allowed to cure for 30 seconds before attaching the vessel to the static/dynamic mock
loop in its natural forward flow orientation. A new nitinol connector and flanged cuff was
used for each experimental set.
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Figure 21: Photograph showing experimental setup for static pressure testing.

The experimental setup (mock loop model) used for static pressure testing is

shown in Figure 21. For each vessel an internal pressure of 0, 50, 100, 150, and 200
mmHg was applied and maintained at steady-steady ( ± 2mmHg) at each pressure step for
30 seconds, and any fluid leakage from the anastomosis was collected in a basin placed
underneath the vessel. Total fluid loss at each pressure step was measured using a
graduated cylinder. Fluid leak rate was calculated using the following equation and
converted to mL/min for reporting:
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑇𝑜𝑡𝑎𝑙 𝐹𝑙𝑢𝑖𝑑 𝐿𝑜𝑠𝑠 (𝑚𝐿) 60𝑠
𝑚𝐿
∗
=
[𝐿𝑒𝑎𝑘 𝑅𝑎𝑡𝑒]
30𝑠
1𝑚𝑖𝑛 𝑚𝑖𝑛
Pressure was set using a pressure hand pump (Meriam Process Technologies,
Cleveland, OH) connected to a SMART Manometer (Meriam Process Technologies,
Cleveland, OH) and an air column compliance chamber via a three-way adapter. Internal
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pressure was measured using a Mikro-tip Pressure Transducer (Millar, Houston, TX) and
continuously monitored with Labchart 8 (AD Instruments, Sydney, Australia).
Table 3: Hemodynamic tuning parameters for each dynamic mock loop condition.

Normal

Hypertension

Heart Failure

Partial Support

Artmean (mmHg)

90 - 110

> 120

< 90

80 - 100

ArtPsystolic (mmHg)

110 - 130

> 140

< 100

100 - 120

ArtPdiastolic (mmHg)

70 - 90

> 100

< 60

60-90

AoFmean (L/min)

4.5 - 5.0

4.5 - 5.0

3.0 - 4.0

4.0 - 5.0

VADFmean (L/min)

0.0

0.0

0.0

2.0 - 3.0

Dynamic pressure testing was completed using the mock flow loop model shown
in Figure 22. The simulated test conditions and hemodynamic parameter requirements of
each condition are shown in Table 3. The following hemodynamic measurements were
continuously recorded for 30 seconds at a 400 Hz sampling rate using Labchart 8:
1. Aortic Pressure (AoP) – mmHg
2. Arterial Pressure (ArtP) – mmHg
3. Aortic Flow (AoF) – L/min
4. Ventricular Assist Device Flow (VADF) – L/min
Fluid leakage from the anastomosis was collected during each data set and measured
using a graduated cylinder. Mikro-tip Pressure Transducers were used to measure
pressure and PXL Clamp-on Flowsensors (Transonic Systems Inc., Ithaca, NY) to
measure flow. The mock ventricle was fitted with a single leaflet mechanical valve at the
inlet and a trileaflet mechanical valve at the outlet with filling and ejection controlled
using a customized pulse duplicator (LB Technology LLC, Louisville, KY). A Castaloy
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clamp (Thermo Fisher Scientific, Waltham, MA) was used to vary afterload resistance.
An air-filled column chamber was used to vary compliance. For the LVAD support test
condition, a HeartMate II (Thoratec Corp., Pleasanton, CA) was used. All hemodynamic
data were signal conditioned using a custom data acquisition system (Koenig et al.,
2004). All pressure and flow transducers were pre- and post-calibrated using an
established technique (Koenig et al., 2004).

Figure 22: Photo and block diagram showing experimental setup for dynamic mock loop pressure tests;
Systemic vascular resistance (SVR); left ventricular assist device (LVAD).

G. Pull-out Testing
The experimental setup for mechanical pull-out testing is shown in Figure 23.
Following completion of the static and dynamic pressure tests, an experienced cardiac
surgeon anastomosed a 15 mm GelWeave graft in a running suture technique with 4-0
Prolene suture onto the same aortic specimen used in static and dynamic pressure tests
(note: same person performed all hand sutured anastomosis for all tests). For each vessel,
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a hand-sewn anastomosis was constructed on the opposite side of the previously attached
anastomosis device. A 12.7 mm diameter round bar was passed through the vessel, which
was then mounted to a 609.6 x 609.6 x 12.5 mm piece of slate. The graft from the
anastomosis being tested was secured in-between two metal plates with sandpaper
adhered to the contacting surfaces. #16 wire was passed through a bored hole through the
plates to attach the graft to a HF-50 Force Gauge (M&A Instruments Inc., Arcadia, CA).
A preload of 2.5 ± 0.5 N was applied before hand-pulling the gauge vertically upwards
until failure and peak force was achieved and recorded. Each vessel and graft was
photographed at the original site of the anastomosis. The hand-sewn anastomosis or
device anastomosis was randomly selected to be tested first, but it was ensured that at
least one from each group was tested first.

Figure 23: Experimental setup for pull-out testing.
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H. Analysis Methods
The mean hemodynamic parameter values recorded during the dynamic pressure
testing were calculated on a beat-to-beat basis using Labchart 8. Previously reported
results for blood leakage rates under normal dynamic pressure (120/80 mmHg) associated
with hand-sewn suture anastomoses (Sergeant, Kocharian, Patel, Pfefferkorn, &
Matonick, 2016) were used for comparison. All statistical tests were performed using
GraphPad Prism (GraphPad Software Inc., La Jolla, CA) and a 95% confidence level (p
< .05) was used for determining statistical significance.
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III. RESULTS

A. Final Prototype Design

Figure 24: Dimensions of the prototype nitinol connector used for experimentation.

43

Figure 25: Dimensions of the prototype flanged cuff used for experimentation.

The dimensions for the nitinol connector and flanged cuff that were tested
experimentally are shown in Figures 24-25. A curved 0.36 mm thick nitinol wire with
intermittent spring elements was selected based on ease of collapsibility, smooth
conformation to the luminal vessel wall, adequate rigidity to remain within the vessel,
and capability to be fastened to a vascular graft. The addition of spring elements
enhanced the collapsibility of the connector and provided a graft attachment point.

B. Static Pressure Testing
A summary of the leak rates for all static pressure steps are presented in Table 4.
There was an increase in mean leak rate with increasing pressure for all device completed
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anastomoses. All leaks were categorized as drips. Notably, a consistently larger leak rate
was reported in vessel #2 at all pressure steps (Figure 26).
Table 4: Mean ± standard deviation of leak rates from static pressure tests.

Pressure
(mmHg)

Leak Rate
(mL/min)

0

0.00 ± 0.00

50

5.6 ± 7.1

100

11.9 ± 11.4

150

22.7 ± 20.7

200

43.6 ± 23.4

70

Laek Rate (mL/min)

60
Vessel 1

50

Vessel 2

40

Vessel 3

30
20
10
0
0

50

100
Pressure (mmHg)

150

200

Figure 26: Leak rates for each vessel during static pressure tests. Vessel 2 consistently showed greater leak
rates at all pressures ≥ 50 mmHg.
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C. Dynamic Pressure Testing
Each of the dynamic pressure test conditions met the aforementioned
hemodynamic requirements for ArtP, AoF, and VADF. Pressure trends consistent with
other mock loop studies (Bartoli et al., 2010; Giridharan et al., 2015) were observed in
ArtPmean, PAoPmean, AoF, and VADF between conditions (Table 5, Figure 27):
1) Increased mean pressures from normal to hypertension
2) Decreased mean pressures and AoF from normal to heart failure
3) Increased mean pressures and flows from heart failure to LVAD support
Sample pressure and flow waveforms for each dynamic pressure test condition are shown
in Figure 28.

Figure 27- Graphs comparing pressure and flows for each dynamic mock loop condition reflecting typical
physiologic trends in hemodynamic parameters associated with each condition; arterial pressure (ArtP);
aortic pressure (AoP); aortic flow (AoF); left ventricular assist device (LVAD).
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Table 5: Mean ± standard deviations of hemodynamic parameter measurements calculated on a beat-tobeat basis for dynamic mock loop tests; arterial pressure (ArtP); aortic pressure (AoP); aortic flow (AoF);
ventricular assist device flow (VADF); left ventricular assist device (LVAD)
Normal
(n=3)

Hypertension
(n=3)

Heart Failure
(n=3)

LVAD Support
(n=3)

ArtPmean (mmHg)

100 ± 2

131 ± 1

79 ± 4

83 ± 7

ArtPsystolic (mmHg)

121 ± 1

153 ± 2

94 ± 4

99 ± 6

ArtPdiastolic (mmHg)

82 ± 2

111 ± 3

65 ± 2

67 ± 5

AoPmean (mmHg)

112 ± 8

143 ± 10

86 ± 10

106 ± 9

AoPsystolic (mmHg)

154 ± 18

187 ± 24

127 ± 24

160 ± 26

AoPdiastolic (mmHg)

64 ± 7

84 ± 13

44 ± 8

55 ± 18

AoFmean (L/min)

4.79 ± 0.14

4.67 ± 0.11

3.65 ± 0.19

4.09 ± 0.09

VADFmean (L/min)

0.00 ± 0.00

0.00 ± 0.00

0.00 ± 0.00

2.49 ± 0.26

Figure 28: Sample waveforms collected for normal, hypertension, heart failure, and LVAD support dynamic
mock loop tests.
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The leak rates recorded for dynamic pressure tests are listed in Table 6, and the
leak rates for the static and dynamic pressure tests are shown in Figure 29. Although a
noticeable positive correlation was observed between mean leak rate and mean pressures,
no statistically discernible differences were observed. The leak rates for normal mock
flow loop condition and literature reported leak rates for sutured anastomosis are shown
in Figure 30. A one-way ANOVA demonstrated a significant difference in leak rate
between the GrAD and sutured anastomosis (p ≤ 0.05) was observed. A Tukey
comparison test showed significant differences in leak rates between the GrAD and
Prolene 2, as well e-PTFE sutures (Table 7, Figure 30). No differences in leak rate
between the GrAD and other sutures were statistically discernible. All leaks were
categorized as drips.
Table 6: Mean ± standard deviation leak rates for dynamic mock loop pressure tests;
left ventricular assist device (LVAD)

Hemodynamic
Condition

Leak Rate
(mL/min)
(n=3)

Normal

22.1 ± 9.3

Hypertension

23.1 ± 10.1

Heart Failure

16.4 ± 6.4

LVAD Support

16.4 ± 4.3
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Table 7: Specifications for typical suture types used for anastomosis; needle:suture diameter ratio (N:S
Ratio); polytetrafluoroethylene (PTFE).
Suture Size

Needle Type N:S Ratio

Suture Material

Hemo-Seal Prolene (HS)

5-0

C-1

1.84:1

Monofilament polypropylene

Prolene 1 (PR1)

5-0

C-1

2.41:1

Monofilament polypropylene

Prolene 2 (PR2)

5-0

C-1

2.06:1

Monofilament polypropylene

e-PTFE (PTFE)

CV-6

TTc-13

1.4:1

Monofilament e-PTFE

Prolene 3

3-0

SH

2.6:1

Monofilament polypropylene

Prolene 4

4-0

SH

3.47:1

Monofilament polypropylene

Prolene 5

5-0

SH

5.2:1

Monofilament polypropylene

Sergeant et al. Study Sutures

Additional Graft Sutures

Figure 29: Leak rates for static and dynamic pressure tests; left ventricular assist device (LVAD).
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Figure 30: Graph comparing mean leak rate from graft anastomosis device (GrAD) and literature reported
leak rate of Hemo-Seal (HS), Prolene (PR 1, PR 2), and expanded-polytetrafluoroethylene (PTFE) sutures.
Asterisks show significant differences between GrAD and PR1 and PTFE (p < .05).

D. Pull-Out Testing
A comparison of peak pull-out forces for the GrAD and suture anastomosis is
shown in Figure 31. The sutured anastomosis had a 19.9 N higher mean peak pull-out
force than the device anastomosis, but paired t-test showed no significant difference in
means.
Sample photos of the anastomosis device and aorta at the site of the anastomosis
after pull-out testing are shown in Figure 32. All modes of failure for the GrAD appeared
to be due to delamination of the adventitia (outermost layer of vessel tissue) based on the
confluent layer of tissue observed on the flange face attached to the aorta. This was
further supported by the discernably continuous difference in tissue color and depth on
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the aorta at the site of the failed anastomoses. No signs of damage were observed in the
nitinol connector or flanged cuff for all samples.

Figure 32: Peak pull-out force for graft anastomosis device (GrAD)
and sutured anastomosis.

A

B

Figure 31: Photographs of the graft anastomosis device (GrAD) after pull-out testing with no indications
of device damage. A) The debonded device with an observable layer of adventitial tissue on the flanged
cuff, 2) Bovine descending aorta after delamination of a portion of the adventitial tissue by the device.
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Sample photos of the suture and aorta at the site of the anastomosis are shown in
Figure 33. The mode of failure for two of the suture anastomoses was due to the tissue
tearing propagating from the suture holes. This was supported by the slits observed at
every suture hole on the aorta and the remaining tissue within the intact sutures. For
Vessel 2, the mode of failure appeared to be in part due to tissue tear propagation, as well
as fracture of the suture. This was supported by the absence of slits propagating from a
portion of the suture holes. Furthermore, a sliver of tissue remained where the suture was
intact, but no tissue remnants were observed where the suture fractured (Figure 33).

A

B

Figure 33: Photographs of the suture anastomosis after pull-out testing. A) Anastomosis site on the aorta
where slits from suture ripping vessel can be observed, B) Fractured suture with a sliver of aortic tissue
remaining.
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IV. DISCUSSION

In regards to static pressure and dynamic pressure testing, all GrADs remained
securely attached throughout all physiological hemodynamic test conditions. All leak
rates were classified as drips that may have clotted if whole blood had been used (instead
of water). The majority of leaks were observed to originate from the vascular graft that
was uncovered by the flanged cuff and from ineffectively closed branching vessels from
the aorta. Leaking innate to the device originated from the attachment of the graft and
flanged cuff. It is speculated that a poor seal was created where the cuff, graft, and
aortotomy interfaced. Alternative adhesives or solutions for attaching the flanged cuff
and graft material may mitigate or effectively seal this connection point from leaking.
Comparison of leak rates under normal physiologic pressure (120/80 mmHg)
between the GrAD and sutures showed statistically significant lower leak rate by the
device compared to Prolene 1 and PTFE suture, and no statistically discernible
differences were observed in comparing Hemo-Seal Prolene and Prolene 2 (Table 07).
Sergeant et al. evaluated needle-hole blood leakage of various suture types from an endto-end anastomosis of ePTFE grafts at normal physiologic pressures (120/80 mmHg)
(Sergeant et al., 2016). Higher needle:suture (N:S) ratios were associated with higher leak
rates; therefore, it can be speculated that leak rates of other common sutures for
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anastomosis with larger N:S ratios (Prolene 3, Prolene 4, Prolene 5) may have resulted in
significantly higher leak rates similar to Prolene 1. There were several differences in
experimental design between the Seargent et al. study and the normal dynamic pressure
test in this project, including: 1) an anticoagulated blood solution as opposed to DI water,
2) non-porous ePTFE grafts were used rather than gelatin-impregnated porous PET.
Anticoagulated blood has been previously shown to leak from a syringe tip at rate 5.5
times slower than water (Elblbesy, 2014). The non-porous ePTFE graft did not contribute
to the total leak rate, whereas leakage from the porous gelatin-impregnated grafts was
included in the total leak rate in these experiments. The lower associated leak rate of
blood and non-porous graft material would suggest that suture leak rates in the Sergeant
el al. study should be less than the device. These variations may have contributed, in part,
to the 11.6% reduction in mean leak rate of Hemo-Seal suture compared to the device,
although it was demonstrated that the GrAD produced similar leak rates as conventional
sutures used for anastomosis.
In regards to peak pull-out strengths, no statistically significant differences were
discerned between GrAD and sutured anastomosis. Based on the GrAD failure mode
attributed to delamination of the adventitial layer of the aorta, pull-out strength is
believed to be dependent on the strength of the bonds between aortic tissue layers
suggesting that the bond strength provided by cyanoacrylate adhesive between the
flanged cuff and aortic tissue is stronger than the bond strength between the layers of the
aorta. Comparatively, pull-out strength for suture anastomosis is believed to be dependent
on the strength of the suture and the strength of the aortic wall against an opening mode
tearing fracture.
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Sutureless connection to the aorta minimizes potential risk of tissue trauma
inherent to the presence of non-absorbable sutures through the tissue. It may also reduce
the time required to complete the anastomosis and be configured for a range of aortic
thicknesses and graft diameters. Since this device employs a two component attachment
method to compress the aortic wall, it is not limited by narrow range of aortic thickness
specifications associated with the Symmetry and Pas-PORT devices. Up-scaling or
down-scaling the connector dimensions to accommodate different graft diameters would
simply require proportional scaling of the frames used to fabricate the rings. In GrAD
design, an angled anastomosis is maintained by the flanged cuff which has been shown to
promote superior blood flow dynamics and reduce the risk of clinical adverse events.
An important design consideration is the selection and/or development of a
surgical adhesive. Acrylate-based adhesives, including cyanoacrylate, have not been
approved for human internal use and have been reported to be toxic and thrombogenic.
Fibrin glue adhesives, which are approved for human internal applications, were
evaluated as a candidate adhesive for the device. However, we chose to use water (rather
than whole blood) to demonstrate early feasibility, which did not allow clot formation
and likely resulted in a higher leak rate. Fibrin sealant has been used to achieve
hemostasis at the higher pressure levels in the arterial systems (B. Baumgartner, Draxler,
& Lewis, 2016; N. Baumgartner et al., 1996; Detweiler, Detweiler, & Fenton, 1999),
warranting further investigation of fibrin and other adhesives as an alternative solution. In
this study, it was demonstrated that cyanoacrylate is capable of securely attaching LVAD
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outflow grafts to the aorta, and is worth further consideration and investigation as a
potential clinical sealant.

A. Limitations
To demonstrate proof-of-concept of device performance and early feasibility of
device function, a small sample size (n=3) for each test was performed. Larger sample
size based upon a power analysis will be required to demonstrate statistical significance,
which will likely be performed once a design freeze has been achieved. A limitation
associated with the static and dynamic leak testing was that in quantifying the leak rate,
the fluid volume from the graft and branching vessels (not completely closed) were
included in the overall leak rate calculation. For example, Vessel #2 was observed to be
leaking in large part from the graft section that was not covered by the flanged cuff,
which may be attributed to protein degradation of the gelatin that was impregnated into
the porous graft. Vessels #1 and #3 were not observed to be leaking as profusely from the
graft during static pressure tests. A second limitation of the pressure experiments was the
use of water rather than whole blood, which represented a lower viscosity as is seen in
anticoagulated blood and a worst case for leak rate. In future testing, the leak rate should
be lower with the use of whole blood. A limitation associated with the pull-out tests was
the apparatus constructed for testing. Since the force gauge was pulled vertically by hand,
inconsistent directional tension may have been applied to each test sample. Second, the
velocity that the force gauge was pulled may have varied for each test sample. These
variables could be addressed if future pull-out experiments were conducted using a
universal testing machine.
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Cryopreservation methodology of the bovine descending aorta specimens may
have altered the natural mechanical and molecular properties compared to fresh harvested
tissue. UW solution is a commonly used solution hypothermic storage of blood vessels to
minimize cellular degeneration (Abrahamse, Dinant, Pfaffendorf, & Van Gulik, 2002).
However, hypothermia and cryopreservation has been shown to induce cellular damage
(Wille, de Groot, & Rauen, 2008). Previous studies comparing vessel mechanics of fresh
and cryopreserved tissues have reported contradictory results on the effects of
cryopreservation, although a majority have found no significant differences (Stemper et
al., 2007). A recent study demonstrated that vessels maintained physiological mechanics
after 3 months of cryopreservation (Stemper et al., 2007). All bovine descending aorta
specimens used for experiments were stored at -80°C for 3 to 4 months before
experiments using similar established methods for cryopreservation. There is still a
potential that the hypothermic storage, tissue handling, and series of experiments could
have altered the behavior of the tissue affecting the results of this project. Fresh aortic
segments may have reduced any variability due to tissue handling or storage.
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V. CONCLUSION

The primary objective of this MEng thesis to develop a novel device that
facilitates LVAD outflow graft anastomosis by demonstrating proof-of-concept and
feasibility of prototype design. The preliminary data demonstrated feasibility as
evidenced by secure connection to the aorta over a wide range of physiologic static and
dynamic pressures, as well as leak rates and connection strength comparable to
conventional hand-sutured anastomosis. Future developmental work should focus on (1)
alternative adhesive exploration and (2) deployment tool. Since the nitinol connector and
flanged cuff are collapsible, the components can be easily loaded into a deployment tool
for device delivery. A dedicated deployment tool would also allow for the device to be
deployed in small surgical windows using less invasive surgical techniques.
Three key characteristics of the prototype GrAD that may facilitate LVAD
outflow graft anastomosis are: 1) sutureless connection to the aorta, 2) adaptable to
various aortic thicknesses and graft diameters, and 3) 30-45 angled anastomosis. This
novel device could provide an alternative method for LVAD outflow graft anastomosis
that may be completed faster, more consistently, and with less dependence on surgical
skill than conventional hand-suturing, thereby potentially allowing outflow anastomosis
to be completed less-invasively. The device enables a sutureless, adaptable, and angled
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anastomosis. Thereby, it has the potential of facilitating less-invasive LVAD
implantation, faster implant time, and improving the reliability and reproducibility with
the potential to improve patient outcomes.
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APPENDIX I: RAW AND ADDITIONAL DATA

Table 8: Static pressure test raw leak rate data.
Pressure (mmHg)
0
50
100
150
200

Vessel 1
Leak Rate (mL/30s) Note
0 Drip
0.6 Drip
1.6 Drip
3.8 Drip
5.4 Drip

Leak Rate (mL/30s)
Vessel 2
Vessel 3
Leak Rate (mL/30s)
Note
Leak Rate (mL/30s)
Note
0 Drip
0 Drip
7.8 Drip
0 Drip
14 Drip (Graft)
2.2 Drip
26 Drip (Graft)
4.2 Drip
32 Drip (Graft)
28 Drip (graft)
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Table 9: Dynamic pressure test leak rate raw data.
Dynamic Pressure Leak Rate Data
Vessel 1
Vessel 2
Vessel 3
Leak Rate (mL/30s) Note Leak Rate (mL/30s)
Note
Leak Rate (mL/30s) Note
Normal
5.6 Drip
17 Drip (graft)
10.5 Drip
Hypertension
5.7 Drip
18 Drip (graft)
11 Drip
Heart Failure
6.8 Drip
12.6 Drip (graft)
5.2 Drip
Partial VAD Support
7.9 Drip
11 Drip (graft)
5.7 Drip
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ArtPsys (mmHg)
ArtPdia (mmHg)
Artm (mmHg)
AoPsys (mmHg)
AoPdia (mmHg)
AoPm (mmHg)
AoFsys (L/min)
AoFdia (L/min)
AoFm (L/min)
VADFsys (L/min)
VADFdia (L/min)
VADFm (L/min)

1
119.7619
79.937
100.1123
156.4987
60.217
108.2612
4.6438
4.5453
4.5974
-0.0032
-0.0053
-0.0043

Normal
SD
3 Mean
2
121.13 1.09
122.4282 121.1913
81.87 2.05
84.7091 80.9522
100.67 1.51
102.7337 99.1709
154.26 18.46
175.6651 130.615
63.85 7.16
57.4825 73.8567
111.95 8.13
123.2161 104.3582
13.62 6.71
15.4334 20.7687
0.65 2.76
-1.1502 -1.4496
4.79 0.14
4.8871
4.894
0.00 0.00
-0.0044 -0.0044
-0.01 0.00
-0.0062 -0.0061
0.00 0.00
-0.0053 -0.0053

Dynamic Pressure Hemodynamic Beat-to-Beat Data
Partial
Heart Failure
Hypertension
3 Mean SD
2
1
3 Mean SD
2
1
3 Mean SD
2
1
153.5128 150.0027 154.6328 152.72 2.42 95.2426 97.0879 90.0558 94.13 3.65 95.8218 94.3037 105.652 98.59 6.16
63.353 65.32 2.47 62.9104 64.8212 72.7795 66.84 5.23
108.7969 114.9775 109.9676 111.25 3.28 64.5176 68.0929
75.775 79.09 3.55 78.9116 79.4807 91.3306 83.24 7.01
130.3919 131.8714 130.3163 130.86 0.88 78.6579 82.8376
191.8276 209.0879 161.1991 187.37 24.25 131.7895 148.44 100.5245 126.92 24.33 163.2917 184.416 132.669 160.13 26.02
79.4422 73.0096 98.1111 83.52 13.04 34.7571 48.9852 47.9365 43.89 7.93 40.2696 48.8792 74.7618 54.64 17.95
139.6164 153.6071 135.0574 142.76 9.67 83.7271 96.6912 78.6808 86.37 9.29 100.8563 116.2664 100.6235 105.92 8.96
12.859 14.7404 10.55 5.71
4.0487
3.6332 13.4689 17.3532 11.49 7.07
4.6316 15.6541 19.0216 13.10 7.53
-0.917 -1.2226 0.60 2.90
3.9461
-0.934 0.52 2.62
3.539 -1.059
4.5116 -1.4528 -1.4766 0.53 3.45
4.1245 4.09 0.09
4.1517
3.9903
3.8654 3.65 0.19
3.5849 3.4992
4.6943 4.67 0.11
4.7672
4.5571
7.7026 5.58 2.51
6.2365
2.8105
-0.003 -0.0046 -0.0045 0.00 0.00
-0.0034 -0.0045 -0.0047 0.00 0.00
-2.499 -2.9211 -0.89 3.16
2.7517
-0.0055 -0.0062 -0.0063 -0.01 0.00 -0.0051 -0.0063 -0.0061 -0.01 0.00
2.3127 2.49 0.26
2.3637
2.7804
-0.0045 -0.0053 -0.0055 -0.01 0.00 -0.0041 -0.0054 -0.0053 0.00 0.00

Table 10: Dynamic pressure test hemodynamic beat-to-beat raw calculations
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Table 11: Pull-out force raw Data.

Peak Pull-out Strength (N)
Device
Suture
1
63.43
53.43
2
31.62
67.95
3
35.66
69.06
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APPENDIX II: STATISTICAL ANALYSIS

A) Dynamic Pressure Leak Rate ANOVA
Table Analyzed

Data 1

ANOVA summary
F
0.4194
P value
0.7441
P value summary
ns
Are differences among means statistically significant? (P < 0.05) No
R square

0.1359

Brown-Forsythe test
F (DFn, DFd)
0.4021 (3, 8)
P value
0.7555
P value summary
ns
Significantly different standard deviations? (P < 0.05)

No

Bartlett's test
Bartlett's statistic (corrected)
P value
P value summary
Significantly different standard deviations? (P < 0.05)
ANOVA table SS
DF
MS
F (DFn, DFd) P value
Treatment (between columns)
117.0 3
39.01 F (3, 8) = 0.4194
0.7441
Residual (within columns) 744.1 8
93.02
Total 861.2 11
Data summary
Number of treatments (columns) 4
Number of values (total)
12
B) Unpaired ANOVA against Literature Data
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P=

Table Analyzed

Data 1

ANOVA summary
F
83.02
P value
< 0.0001
P value summary
****
Are differences among means statistically significant? (P < 0.05) Yes
R square

0.8098

Brown-Forsythe test
F (DFn, DFd)
P value
P value summary
Significantly different standard deviations? (P < 0.05)
Bartlett's test
Bartlett's statistic (corrected)
P value
P value summary
Significantly different standard deviations? (P < 0.05)
ANOVA table SS
DF
MS
Treatment (between columns)
0.0001
Residual (within columns) 3879
Total 20395 82
Data summary
Number of treatments (columns)
Number of values (total)
83

F (DFn, DFd) P value
16516 4
4129 F (4, 78) = 83.02
78

49.73

5
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P<

B) Tukey Test of Leak Rates from Device vs Literature
Number of families 1
Number of comparisons per family 10
Alpha 0.05
Tukey's multiple comparisons test
Summary
Device vs. SH
Device vs. PR 1
Device vs. PR 2
Device vs. PTFE
SH vs. PR 1 -37.40
SH vs. PR 2 -14.00
SH vs. PTFE -26.70
PR 1 vs. PR 2
PR 1 vs. PTFE
PR 2 vs. PTFE

Test details
q

2.270 -9.923 to 14.46
-35.13 -47.32 to -22.94
-11.73 -23.92 to 0.4635
-24.43 -36.62 to -12.24
-43.63 to -31.17
Yes
-20.23 to -7.772
Yes
-32.93 to -20.47
Yes
23.40 17.17 to 29.63 Yes
10.70 4.472 to 16.93 Yes
-12.70 -18.93 to -6.472

Mean 1
DF

Device vs. SH
Device vs. PR 1
Device vs. PR 2
Device vs. PTFE
SH vs. PR 1 19.80
SH vs. PR 2 19.80
SH vs. PTFE 19.80
PR 1 vs. PR 2
PR 1 vs. PTFE
PR 2 vs. PTFE

Mean Diff.

22.07
22.07
22.07
22.07
57.20
33.80
46.50
57.20
57.20
33.80

95% CI of diff.

Significant?

No
Yes
No
Yes
****
****
****
****
****
Yes

A-B
A-C
A-D
A-E

ns
****
ns
****
B-C
B-D
B-E
C-D
C-E
****

D-E

n1

Mean 2

Mean Diff.

SE of diff.

19.80
57.20
33.80
46.50
-37.40
-14.00
-26.70
33.80
46.50
46.50

4.366
4.366
4.366
4.366
20
20
20
2.230
2.230
2.230

20
20
20
20
23.72
8.878
16.93
20
20
20

2.270
-35.13
-11.73
-24.43
2.230
2.230
2.230
23.40
10.70
-12.70
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3
3
3
3
20
20
20
20
20
20

0.7352 78
11.38 78
3.799 78
7.913 78
78
78
78
14.84 78
6.785 78
8.054 78

n2

C) Paired T-Test for Pull-Out Tests
Table Analyzed
Column A
vs.
vs.
Column B

Paired t test data

Device
Suture

Paired t test
P value
0.3151
P value summary
ns
Significantly different? (P < 0.05) No
One- or two-tailed P value? Two-tailed
t, df t=1.329 df=2
Number of pairs
3
How big is the difference?
Mean of differences -19.91
SD of differences 25.94
SEM of differences 14.98
95% confidence interval
-84.36 to 44.54
R squared 0.4690
How effective was the pairing?
Correlation coefficient (r) -0.9837
P value (one tailed) 0.0575
P value summary
ns
Was the pairing significantly effective?

No
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